Literature DB >> 20362747

Does chronic microaspiration cause idiopathic pulmonary fibrosis?

Joyce S Lee1, Harold R Collard, Ganesh Raghu, Matthew P Sweet, Steven R Hays, Guilherme M Campos, Jeffrey A Golden, Talmadge E King.   

Abstract

Idiopathic pulmonary fibrosis is a diffuse fibrotic lung disease of unknown etiology with no effective treatment. Emerging data support a role for chronic microaspiration (ie, subclinical aspiration of small droplets) in the pathogenesis and natural history of idiopathic pulmonary fibrosis. However, the precise relationship between chronic microaspiration and idiopathic pulmonary fibrosis remains unknown. Gastroesophageal reflux, a presumed risk factor for microaspiration, has been strongly associated with idiopathic pulmonary fibrosis with an estimated prevalence of up to 90%. This review aims to describe the relationship between chronic microaspiration and idiopathic pulmonary fibrosis by laying out the clinical and biologic rationale for this relationship and exploring the scientific evidence available. The gaps in our current understanding of the diagnosis of chronic microaspiration and idiopathic pulmonary fibrosis and the ongoing uncertainties in management and treatment will be highlighted. Defining the role of chronic microaspiration in idiopathic pulmonary fibrosis is essential as it has potential clinical, pathobiological, and treatment implications for this deadly disease.

Entities:  

Mesh:

Year:  2010        PMID: 20362747      PMCID: PMC2851633          DOI: 10.1016/j.amjmed.2009.07.033

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  66 in total

Review 1.  American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS).

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2000-02       Impact factor: 21.405

Review 2.  Aspiration pneumonitis and aspiration pneumonia.

Authors:  P E Marik
Journal:  N Engl J Med       Date:  2001-03-01       Impact factor: 91.245

Review 3.  Acute exacerbations of idiopathic pulmonary fibrosis.

Authors:  Harold R Collard; Bethany B Moore; Kevin R Flaherty; Kevin K Brown; Robert J Kaner; Talmadge E King; Joseph A Lasky; James E Loyd; Imre Noth; Mitchell A Olman; Ganesh Raghu; Jesse Roman; Jay H Ryu; David A Zisman; Gary W Hunninghake; Thomas V Colby; Jim J Egan; David M Hansell; Takeshi Johkoh; Naftali Kaminski; Dong Soon Kim; Yasuhiro Kondoh; David A Lynch; Joachim Müller-Quernheim; Jeffrey L Myers; Andrew G Nicholson; Moisés Selman; Galen B Toews; Athol U Wells; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2007-06-21       Impact factor: 21.405

4.  Pepsin as a marker for pulmonary aspiration.

Authors:  Norma A Metheny; Yie-Hwa Chang; Jing Song Ye; Sharon J Edwards; Julie Defer; Thomas E Dahms; Barbara J Stewart; Kathleen S Stone; Ray E Clouse
Journal:  Am J Crit Care       Date:  2002-03       Impact factor: 2.228

Review 5.  Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy.

Authors:  M Selman; T E King; A Pardo
Journal:  Ann Intern Med       Date:  2001-01-16       Impact factor: 25.391

6.  Comparison of a salivary/sputum pepsin assay with 24-hour esophageal pH monitoring for detection of gastric reflux into the proximal esophagus, oropharynx, and lung.

Authors:  Sunitha Potluri; Frank Friedenberg; Henry P Parkman; Alan Chang; Robert MacNeal; Christopher Manus; Matthew Q Bromer; Aslam Malik; Robert S Fisher; Thomas Nugent; Vinod K Thangada; Friedrich Kueppers; Larry S Miller
Journal:  Dig Dis Sci       Date:  2003-09       Impact factor: 3.199

7.  Interrater reliability of videofluoroscopic swallow evaluation.

Authors:  Sandro J Stoeckli; Thierry A G M Huisman; Burkhardt Seifert; Bonnie J W Martin-Harris
Journal:  Dysphagia       Date:  2003       Impact factor: 3.438

Review 8.  The role of gastroesophageal reflux in idiopathic pulmonary fibrosis.

Authors:  Ganesh Raghu
Journal:  Am J Med       Date:  2003-08-18       Impact factor: 4.965

9.  Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation.

Authors:  R Duane Davis; Christine L Lau; Steve Eubanks; Robert H Messier; Denis Hadjiliadis; Mark P Steele; Scott M Palmer
Journal:  J Thorac Cardiovasc Surg       Date:  2003-03       Impact factor: 5.209

10.  Pepsin, a biomarker of gastric aspiration in lung allografts: a putative association with rejection.

Authors:  Rachel Stovold; Ian A Forrest; Paul A Corris; Desmond M Murphy; Jaclyn A Smith; Sam Decalmer; Gail E Johnson; John H Dark; Jeffrey P Pearson; Chris Ward
Journal:  Am J Respir Crit Care Med       Date:  2007-04-05       Impact factor: 21.405

View more
  64 in total

1.  Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis.

Authors:  Joyce S Lee; Jay H Ryu; Brett M Elicker; Carmen P Lydell; Kirk D Jones; Paul J Wolters; Talmadge E King; Harold R Collard
Journal:  Am J Respir Crit Care Med       Date:  2011-06-23       Impact factor: 21.405

Review 2.  Promising new treatment targets in patients with fibrosing lung disorders.

Authors:  Martina Sterclova; Martina Vasakova
Journal:  World J Clin Cases       Date:  2014-11-16       Impact factor: 1.337

3.  Identification of Helicobacter pylori VacA in human lung and its effects on lung cells.

Authors:  Shota Nakashima; Tomoyuki Kakugawa; Hirokazu Yura; Masaomi Tomonaga; Tatsuhiko Harada; Atsuko Hara; Shintaro Hara; Masayuki Nakano; Eiki Yamasaki; Noriho Sakamoto; Yuji Ishimatsu; Hajime Isomoto; Bernadette R Gochuico; Anthony F Suffredini; Hiroshi Mukae; Hisao Kurazono; Toshiya Hirayama; Joel Moss; Shigeru Kohno
Journal:  Biochem Biophys Res Commun       Date:  2015-03-25       Impact factor: 3.575

4.  Airway reflux, cough and respiratory disease.

Authors:  Ian D Molyneux; Alyn H Morice
Journal:  Ther Adv Chronic Dis       Date:  2011-07       Impact factor: 5.091

5.  Respiratory dysfunction is common in patients with achalasia and improves after pneumatic dilation.

Authors:  Mahesh Gupta; Uday C Ghoshal; Shikha Jindal; Asha Misra; Alok Nath; Vivek A Saraswat
Journal:  Dig Dis Sci       Date:  2013-12-20       Impact factor: 3.199

Review 6.  Viral infection and aging as cofactors for the development of pulmonary fibrosis.

Authors:  Payal K Naik; Bethany B Moore
Journal:  Expert Rev Respir Med       Date:  2010-12       Impact factor: 3.772

7.  Epidemiology of idiopathic pulmonary fibrosis: a population-based study in primary care.

Authors:  Sergio Harari; Michele Davì; Alice Biffi; Antonella Caminati; Alessandra Ghirardini; Valeria Lovato; Claudio Cricelli; Francesco Lapi
Journal:  Intern Emerg Med       Date:  2019-09-20       Impact factor: 3.397

Review 8.  The pulmonary side of reflux disease: from heartburn to lung fibrosis.

Authors:  Marco E Allaix; P Marco Fisichella; Imre Noth; Bernardino M Mendez; Marco G Patti
Journal:  J Gastrointest Surg       Date:  2013-04-25       Impact factor: 3.452

9.  A review of current and novel therapies for idiopathic pulmonary fibrosis.

Authors:  Rokhsara Rafii; Maya M Juarez; Timothy E Albertson; Andrew L Chan
Journal:  J Thorac Dis       Date:  2013-02       Impact factor: 2.895

10.  Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials.

Authors:  Joyce S Lee; Harold R Collard; Kevin J Anstrom; Fernando J Martinez; Imre Noth; Rhonda S Roberts; Eric Yow; Ganesh Raghu
Journal:  Lancet Respir Med       Date:  2013-06-14       Impact factor: 30.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.